Biocept, Inc. Release: Company Awarded Patent In Australia For The Use Of Antibodies In Microchannels To Capture Circulating Tumor Cells And Other Rare Cells Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz January 9, 2018 Little Idorsia Scores $230M+ R&D Deal With Johnson & Johnson December 3, 2017 Aeglea BioTherapeutics Updates Phase I/II Trial Data March 12, 2018